Drägerwerk AG & Co. KGaA Logo

Drägerwerk AG & Co. KGaA

0MT8.L

(0.0)
Stock Price

43,00 EUR

3.53% ROA

8.1% ROE

9.07x PER

Market Cap.

908.539.971,00 EUR

18.71% DER

0.29% Yield

3.27% NPM

Drägerwerk AG & Co. KGaA Stock Analysis

Drägerwerk AG & Co. KGaA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Drägerwerk AG & Co. KGaA Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Drägerwerk AG & Co. KGaA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Drägerwerk AG & Co. KGaA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Drägerwerk AG & Co. KGaA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Drägerwerk AG & Co. KGaA Revenue
Year Revenue Growth
2012 2.373.495.000
2013 2.374.164.000 0.03%
2014 2.434.656.000 2.48%
2015 2.608.920.000 6.68%
2016 2.523.838.000 -3.37%
2017 2.572.256.000 1.88%
2018 2.595.010.000 0.88%
2019 2.780.824.000 6.68%
2020 3.406.276.000 18.36%
2021 3.328.419.000 -2.34%
2022 3.045.227.000 -9.3%
2023 3.154.008.000 3.45%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Drägerwerk AG & Co. KGaA Research and Development Expenses
Year Research and Development Expenses Growth
2012 197.338.000
2013 201.530.000 2.08%
2014 212.020.000 4.95%
2015 231.097.000 8.25%
2016 219.022.000 -5.51%
2017 234.674.000 6.67%
2018 252.171.000 6.94%
2019 263.707.000 4.37%
2020 289.595.000 8.94%
2021 328.578.000 11.86%
2022 343.482.000 4.34%
2023 325.644.000 -5.48%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Drägerwerk AG & Co. KGaA General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 139.587.000
2013 119.972.000 -16.35%
2014 199.956.000 40%
2015 250.200.000 20.08%
2016 206.495.000 -21.17%
2017 197.710.000 -4.44%
2018 198.458.000 0.38%
2019 219.428.000 9.56%
2020 248.120.000 11.56%
2021 261.113.999 4.98%
2022 258.659.000 -0.95%
2023 221.892.000 -16.57%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Drägerwerk AG & Co. KGaA EBITDA
Year EBITDA Growth
2012 283.446.000
2013 260.397.000 -8.85%
2014 237.560.000 -9.61%
2015 140.472.000 -69.12%
2016 204.430.000 31.29%
2017 221.143.000 7.56%
2018 137.691.000 -60.61%
2019 157.569.000 12.62%
2020 476.586.000 66.94%
2021 374.430.000 -27.28%
2022 1.551.000 -24041.2%
2023 252.204.000 99.39%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Drägerwerk AG & Co. KGaA Gross Profit
Year Gross Profit Growth
2012 1.167.010.000
2013 1.147.565.000 -1.69%
2014 1.138.022.000 -0.84%
2015 1.171.671.000 2.87%
2016 1.135.428.000 -3.19%
2017 1.152.160.000 1.45%
2018 1.108.047.000 -3.98%
2019 1.188.420.000 6.76%
2020 1.608.894.000 26.13%
2021 1.540.912.000 -4.41%
2022 1.238.386.000 -24.43%
2023 1.387.380.000 10.74%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Drägerwerk AG & Co. KGaA Net Profit
Year Net Profit Growth
2012 127.036.000
2013 114.553.000 -10.9%
2014 96.597.000 -18.59%
2015 25.045.000 -285.69%
2016 60.854.000 58.84%
2017 73.603.000 17.32%
2018 25.684.000 -186.57%
2019 24.934.000 -3.01%
2020 188.588.000 86.78%
2021 134.319.000 -40.4%
2022 -64.562.000 308.05%
2023 70.492.000 191.59%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Drägerwerk AG & Co. KGaA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 8
2013 7 -16.67%
2014 6 -20%
2015 1 -400%
2016 3 66.67%
2017 4 25%
2018 1 -300%
2019 1 0%
2020 10 90%
2021 7 -42.86%
2022 -3 333.33%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Drägerwerk AG & Co. KGaA Free Cashflow
Year Free Cashflow Growth
2012 118.374.000
2013 -13.180.000 998.13%
2014 99.108.000 113.3%
2015 -70.288.000 241%
2016 122.024.000 157.6%
2017 77.339.000 -57.78%
2018 -53.018.000 245.87%
2019 105.908.000 150.06%
2020 349.961.000 69.74%
2021 283.657.000 -23.37%
2022 -223.942.000 226.67%
2023 42.257.000 629.95%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Drägerwerk AG & Co. KGaA Operating Cashflow
Year Operating Cashflow Growth
2012 176.754.000
2013 68.341.000 -158.64%
2014 187.982.000 63.64%
2015 39.861.000 -371.59%
2016 195.322.000 79.59%
2017 143.336.000 -36.27%
2018 4.090.000 -3404.55%
2019 164.420.000 97.51%
2020 459.980.000 64.25%
2021 384.886.000 -19.51%
2022 -144.228.000 366.86%
2023 54.105.000 366.57%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Drägerwerk AG & Co. KGaA Capital Expenditure
Year Capital Expenditure Growth
2012 58.380.000
2013 81.521.000 28.39%
2014 88.874.000 8.27%
2015 110.149.000 19.31%
2016 73.298.000 -50.28%
2017 65.997.000 -11.06%
2018 57.108.000 -15.57%
2019 58.512.000 2.4%
2020 110.019.000 46.82%
2021 101.229.000 -8.68%
2022 79.714.000 -26.99%
2023 11.848.000 -572.81%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Drägerwerk AG & Co. KGaA Equity
Year Equity Growth
2012 729.661.000
2013 815.967.000 10.58%
2014 896.606.000 8.99%
2015 945.929.999 5.21%
2016 1.003.516.000 5.74%
2017 1.068.344.000 6.07%
2018 1.080.660.000 1.14%
2019 1.076.359.000 -0.4%
2020 1.033.810.999 -4.12%
2021 1.260.494.999 17.98%
2022 1.319.431.000 4.47%
2023 1.382.107.000 4.53%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Drägerwerk AG & Co. KGaA Assets
Year Assets Growth
2012 2.100.103.000
2013 2.065.011.000 -1.7%
2014 2.234.110.000 7.57%
2015 2.311.397.000 3.34%
2016 2.312.325.000 0.04%
2017 2.354.366.000 1.79%
2018 2.410.227.000 2.32%
2019 2.570.910.000 6.25%
2020 3.305.992.000 22.23%
2021 3.178.263.000 -4.02%
2022 3.106.576.000 -2.31%
2023 3.001.571.000 -3.5%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Drägerwerk AG & Co. KGaA Liabilities
Year Liabilities Growth
2012 1.370.442.000
2013 1.249.044.000 -9.72%
2014 1.337.504.000 6.61%
2015 1.365.467.000 2.05%
2016 1.308.809.000 -4.33%
2017 1.286.022.000 -1.77%
2018 1.329.567.000 3.28%
2019 1.494.551.000 11.04%
2020 2.272.181.000 34.22%
2021 1.917.768.000 -18.48%
2022 1.787.145.000 -7.31%
2023 1.619.464.000 -10.35%

Drägerwerk AG & Co. KGaA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
177.99
Net Income per Share
5
Price to Earning Ratio
9.07x
Price To Sales Ratio
0.27x
POCF Ratio
4.68
PFCF Ratio
8
Price to Book Ratio
0.62
EV to Sales
0.22
EV Over EBITDA
2.79
EV to Operating CashFlow
4.01
EV to FreeCashFlow
6.4
Earnings Yield
0.11
FreeCashFlow Yield
0.12
Market Cap
0,91 Bil.
Enterprise Value
0,73 Bil.
Graham Number
90.91
Graham NetNet
-28.61

Income Statement Metrics

Net Income per Share
5
Income Quality
1.94
ROE
0.07
Return On Assets
0.03
Return On Capital Employed
0.08
Net Income per EBT
0.76
EBT Per Ebit
0.81
Ebit per Revenue
0.05
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0.1
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.43
Operating Profit Margin
0.05
Pretax Profit Margin
0.04
Net Profit Margin
0.03

Dividends

Dividend Yield
0
Dividend Yield %
0.29
Payout Ratio
0.04
Dividend Per Share
0.13

Operating Metrics

Operating Cashflow per Share
9.68
Free CashFlow per Share
6.05
Capex to Operating CashFlow
-0.37
Capex to Revenue
-0.02
Capex to Depreciation
-0.5
Return on Invested Capital
0.06
Return on Tangible Assets
0.04
Days Sales Outstanding
74.46
Days Payables Outstanding
38.4
Days of Inventory on Hand
150.1
Receivables Turnover
4.9
Payables Turnover
9.51
Inventory Turnover
2.43
Capex per Share
-3.62

Balance Sheet

Cash per Share
9,66
Book Value per Share
73,53
Tangible Book Value per Share
55.16
Shareholders Equity per Share
73.53
Interest Debt per Share
13.76
Debt to Equity
0.19
Debt to Assets
0.09
Net Debt to EBITDA
-0.7
Current Ratio
1.83
Tangible Asset Value
1,03 Bil.
Net Current Asset Value
0,19 Bil.
Invested Capital
0.19
Working Capital
0,82 Bil.
Intangibles to Total Assets
0.12
Average Receivables
0,67 Bil.
Average Payables
0,20 Bil.
Average Inventory
776863000
Debt to Market Cap
0.28

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Drägerwerk AG & Co. KGaA Dividends
Year Dividends Growth
2011 1
2012 0 0%
2013 1 0%
2014 1 0%
2015 1 100%
2016 0 0%
2017 0 0%
2023 0 0%

Drägerwerk AG & Co. KGaA Profile

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.

CEO
Mr. Stefan A. Drager B.A.
Employee
15.171
Address
Moislinger Allee 53-55
Lübeck, 23558

Drägerwerk AG & Co. KGaA Executives & BODs

Drägerwerk AG & Co. KGaA Executives & BODs
# Name Age
1 Dr. Reiner Piske
Executive Board Member for Sales & Human Resources - Drägerwerk Verwaltungs AG
70
2 Mr. Gert-Hartwig Lescow
Chief Financial Officer, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG
70
3 Mr. Welf Böttcher
Head of Corporate Communications
70
4 Mr. Stefan A. Drager B.A.
Chairman of the Executive Board - Drägerwerk Verwaltungs AG
70
5 Mr. Anton Schrofner
Executive Board Member for Medical Division - Drägerwerk Verwaltungs AG
70
6 Mr. Rainer Klug
Executive Board Member for Safety Division - Drägerwerk Verwaltungs AG
70
7 Thomas Fischler
Head of Treasury & Investor Relations
70

Drägerwerk AG & Co. KGaA Competitors